Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ovulation suppression for endometriosis.

E Hughes1, D Fedorkow, J Collins

  • 1Rm HSC-4F7, Dept of Obstetrics & Gynecol, McMaster University, 1200 Main St West, Hamilton, Ontario, Canada, L8N 3Z5.

The Cochrane Database of Systematic Reviews
|August 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fluid infusion during postpartum hemorrhage: a secondary analysis of the Obstetric Bleeding Study (OBS) Plus prospective observational study.

International journal of obstetric anesthesia·2026
Same author

Precarious but Possible: A Qualitative Study of the Landscape of Gig Work for People Living with Disabilities and Future Recommendations for Best Practices.

Journal of occupational rehabilitation·2025
Same author

Azimuthal Correlations within Exclusive Dijets with Large Momentum Transfer in Photon-Lead Collisions.

Physical review letters·2023
Same author

Cognition and freezing of gait in Parkinson's disease: A systematic review and meta-analysis.

Neuroscience and biobehavioral reviews·2023
Same author

Measurements of the associated production of a W boson and a charm quark in proton-proton collisions at <math> </math>.

The European physical journal. C, Particles and fields·2022
Same author

Sustainable plastic waste management in a circular economy.

Heliyon·2022

Ovulation suppression treatments for endometriosis-associated subfertility show no significant pregnancy benefit compared to placebo or danazol. These therapies do not outweigh the risk of side effects.

Area of Science:

  • Reproductive Endocrinology
  • Gynecology
  • Clinical Trials

Background:

  • Endometriosis involves endometrial tissue outside the uterus and is estrogen-dependent.
  • Therapeutic strategies often target hormonal dependency to improve fertility.
  • Ovulation suppression agents are commonly used to manage endometriosis-associated subfertility.

Purpose of the Study:

  • To evaluate the efficacy of ovulation suppression agents versus placebo or no treatment for endometriosis-associated subfertility.
  • To compare the effectiveness of various ovulation suppression agents against danazol in treating endometriosis-associated subfertility.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) identified through comprehensive database searches (Cochrane, MEDLINE, EMBASE) and expert contact.

Related Experiment Videos

  • Included trials compared ovulation suppression agents (danazol, medroxy progesterone acetate, gestrinone, oral contraceptives, GnRH analogues) with placebo or danazol.
  • Data extraction and validity assessment were performed independently by two reviewers, with statistical analysis using odds ratios and heterogeneity assessment.

    • Main Results:

    • Ovulation suppression showed no statistically significant benefit for pregnancy compared to placebo or no treatment (OR 0.74; 95% CI 0.48 to 1.15).
    • No significant difference in pregnancy rates was observed when comparing all ovulation suppression agents to danazol (OR 1.3; 95% CI 0.97 to 1.76).
    • Direct comparison of GnRH analogues and danazol also yielded no statistically significant difference in pregnancy outcomes (OR 1.29; 95% CI 0.9 to 1.85).

    Conclusions:

    • The evaluated ovulation suppression treatments do not demonstrate a significant increase in pregnancy odds for endometriosis-associated subfertility.
    • The potential benefits of these treatments do not justify the associated risks of side effects.
    • Further research may be needed to explore alternative or refined therapeutic approaches.